1. Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia
by Partow Kebriaei, Michelle A. Detry, Sergio Giralt, Antonio Carrasco-Yalan, Athanasios Anagnostopoulos, Daniel Couriel, Issa F. Khouri, Paolo Anderlini, Chitra Hosing, Amin Alousi, Richard E. Champlin, and Marcos de Lima
Blood
Volume 110(9):
November 1, 2007
©2007 by American Society of Hematology

2. Probabilities of survival and progression.
Probabilities of survival and progression. The median survival time was 1.86 years (95% CI, ), with overall survival of 48% and 33% at 2 and 5 years, respectively. The median progression-free time was 0.25 years (95% CI, ), with progression-free survival of 29% and 20% at 2 and 5 years, respectively.
Partow Kebriaei et al. Blood 2007;110:
©2007 by American Society of Hematology